2Wienen W,Stassen JM,Priepke H,et al.In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran andits orally active prodrug,dabigatran etexilate[J].Thromb Haemost,2007,98(1):155-162.
3Connolly SJ,Ezekowitz MD,Yusuf S,et al.Dabigatran versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2009,361(12):1139.
2Prystowsky EN, Benson DW Jr, Fuster V, et at. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology[J]. Circulation, 1996 ,93 (6) : 1262-1277.
3Wienen W,Stassen JM,Priepke H, et al. In-vitro profile andex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate [J]. Thromb Haemost, 2007,98 (1) : 155-162.
4Eriksson BI,Dahl OE,Ahnfelt L,et al. Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO 1[J]. J Thromb Haemost, 2004,2(9) :1573-1580.
5Eriksson BI, Dabl OE, Hettiarachchi R, et al. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial [J]. J Thromb Haemost, 2005,3 (1 ) : 103-111.
6Eriksson BI, Dahl OE, Roseneher N, et at. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial [J]. J Thromb Haemost ,2007,5 (11) :2178-2185.
7Eriksson BI, Dabl OE, Rosencher N , et at. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial [J] . Lancet, 2007,370(9591) :949-956.
8Connolly SJ,Ezekowitz MD, YusufS,et at. Dabigatran versus warfarin in patients with atrial fibrillation [J]. N Engl J Med, 2009, 361 (12) : 1139-1151.
9Garber ST, Sivakumar W, Schmidt RH. Neurosurgical complications of direct thrombin inhibitors-catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran[J]. J Neurosurg, 2012,116(5) :1093-1096.
10Edward C. Jauch,Jeffrey L. Saver,Harold P. Adams,Askiel Bruno,J.J. (Buddy) Connors,Bart M. Demaerschalk,Pooja Khatri,Paul W. McMullan,Adnan I. Qureshi,Kenneth Rosenfield,Phillip A. Scott,Debbie R. Summers,David Z. Wang,Max Wintermark,Howard Yonas,李海峰(译),岳耀先(译),王琦(译),张贤军(译),丁晓君(译).急性缺血性卒中患者早期处理指南：美国心脏协会／美国卒中协会对医疗专业人员的指南（续前）[J].国际脑血管病杂志,2013,21(8):564-605. 被引量：988
